Literature DB >> 27459945

The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Masayuki Nagahashi1, Kizuki Yuza2, Yuki Hirose2, Masato Nakajima2, Rajesh Ramanathan3, Nitai C Hait4, Phillip B Hylemon5, Huiping Zhou5, Kazuaki Takabe6, Toshifumi Wakai2.   

Abstract

Based on research carried out over the last decade, it has become increasingly evident that bile acids act not only as detergents, but also as important signaling molecules that exert various biological effects via activation of specific nuclear receptors and cell signaling pathways. Bile acids also regulate the expression of numerous genes encoding enzymes and proteins involved in the synthesis and metabolism of bile acids, glucose, fatty acids, and lipoproteins, as well as energy metabolism. Receptors activated by bile acids include, farnesoid X receptor α, pregnane X receptor, vitamin D receptor, and G protein-coupled receptors, TGR5, muscarinic receptor 2, and sphingosine-1-phosphate receptor (S1PR)2. The ligand of S1PR2, sphingosine-1-phosphate (S1P), is a bioactive lipid mediator that regulates various physiological and pathophysiological cellular processes. We have recently reported that conjugated bile acids, via S1PR2, activate and upregulate nuclear sphingosine kinase 2, increase nuclear S1P, and induce genes encoding enzymes and transporters involved in lipid and sterol metabolism in the liver. Here, we discuss the role of bile acids and S1P signaling in the regulation of hepatic lipid metabolism and in hepatobiliary diseases.

Entities:  

Keywords:  bile duct cancer; fatty acid; liver metabolism; lysosphingolipid; sphingosine kinase

Mesh:

Substances:

Year:  2016        PMID: 27459945      PMCID: PMC5003161          DOI: 10.1194/jlr.R069286

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  61 in total

Review 1.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

Review 2.  Molecular and physiological functions of sphingosine 1-phosphate transporters.

Authors:  Tsuyoshi Nishi; Naoki Kobayashi; Yu Hisano; Atsuo Kawahara; Akihito Yamaguchi
Journal:  Biochim Biophys Acta       Date:  2013-08-04

3.  Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.

Authors:  Kazuaki Takabe; Roger H Kim; Jeremy C Allegood; Poulami Mitra; Subramaniam Ramachandran; Masayuki Nagahashi; Kuzhuvelil B Harikumar; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

4.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 5.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

Review 6.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

7.  Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.

Authors:  Ji Miao; Zhen Xiao; Deepthi Kanamaluru; Gyesik Min; Peter M Yau; Timothy D Veenstra; Ewa Ellis; Steve Strom; Kelly Suino-Powell; H Eric Xu; Jongsook Kim Kemper
Journal:  Genes Dev       Date:  2009-04-15       Impact factor: 11.361

8.  Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network.

Authors:  Masayuki Nagahashi; Eugene Y Kim; Akimitsu Yamada; Subramaniam Ramachandran; Jeremy C Allegood; Nitai C Hait; Michael Maceyka; Sheldon Milstien; Kazuaki Takabe; Sarah Spiegel
Journal:  FASEB J       Date:  2012-11-24       Impact factor: 5.191

9.  Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.

Authors:  Kai Liu; Tai L Guo; Nitai C Hait; Jeremy Allegood; Hardik I Parikh; Wenfang Xu; Glen E Kellogg; Steven Grant; Sarah Spiegel; Shijun Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 10.  Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.

Authors:  Eric Kwong; Yunzhou Li; Phillip B Hylemon; Huiping Zhou
Journal:  Acta Pharm Sin B       Date:  2015-02-09       Impact factor: 11.413

View more
  30 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

2.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

3.  Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.

Authors:  Eric K Kwong; Xiaojiaoyang Li; Phillip B Hylemon; Huiping Zhou
Journal:  Curr Pharmacol Rep       Date:  2017-06-20

4.  Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.

Authors:  Masayuki Nagahashi; Akimitsu Yamada; Eriko Katsuta; Tomoyoshi Aoyagi; Wei-Ching Huang; Krista P Terracina; Nitai C Hait; Jeremy C Allegood; Junko Tsuchida; Kizuki Yuza; Masato Nakajima; Manabu Abe; Kenji Sakimura; Sheldon Milstien; Toshifumi Wakai; Sarah Spiegel; Kazuaki Takabe
Journal:  Cancer Res       Date:  2018-01-19       Impact factor: 12.701

5.  Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice.

Authors:  Liansheng Zhong; Ji Na Kong; Michael B Dinkins; Silvia Leanhart; Zhihui Zhu; Stefka D Spassieva; Haiyan Qin; Hsuan-Pei Lin; Ahmed Elsherbini; Rebecca Wang; Xue Jiang; Mariana Nikolova-Karakashian; Guanghu Wang; Erhard Bieberich
Journal:  J Lipid Res       Date:  2018-03-22       Impact factor: 5.922

6.  The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.

Authors:  Yongqing Wang; Hiroaki Aoki; Jing Yang; Kesong Peng; Runping Liu; Xiaojiaoyang Li; Xiaoyan Qiang; Lixin Sun; Emily C Gurley; Guanhua Lai; Luyong Zhang; Guang Liang; Masayuki Nagahashi; Kazuaki Takabe; William M Pandak; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

7.  Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice.

Authors:  Prasant Kumar Jena; Lili Sheng; Kyle Mcneil; Thinh Q Chau; Sebastian Yu; Maija Kiuru; Maxwell A Fung; Samuel T Hwang; Yu-Jui Yvonne Wan
Journal:  J Dermatol Sci       Date:  2019-06-08       Impact factor: 4.563

Review 8.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

Review 9.  Mechanisms of cholangiocyte responses to injury.

Authors:  Keisaku Sato; Fanyin Meng; Thao Giang; Shannon Glaser; Gianfranco Alpini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-23       Impact factor: 5.187

10.  Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids.

Authors:  Kosuke Murakami; Victoria R Tenge; Umesh C Karandikar; Shih-Ching Lin; Sasirekha Ramani; Khalil Ettayebi; Sue E Crawford; Xi-Lei Zeng; Frederick H Neill; B Vijayalakshmi Ayyar; Kazuhiko Katayama; David Y Graham; Erhard Bieberich; Robert L Atmar; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.